Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Biochem Pharmacol ; 81(3): 451-8, 2011 Feb 01.
Article in English | MEDLINE | ID: mdl-21056031

ABSTRACT

Inflammatory conditions are characterized by continuous overproduction of nitric oxide (NO) that can contribute to cell survival but also to cell demise by affecting apoptosis. These facts are important in regulation of hepatic fibrogenesis during exposure to inflammatory stress, since elevated NO may pose the risk of cells with a pro-fibrogenic phenotype giving rise to a sustained proliferation leading to chronic fibrosis. Since nitration of tyrosine residues occurs in a range of diseases involving inflammation, we tested the hypothesis that nitration of specific proteins could result in apoptosis of hepatic stellate cells (HSC), the primary cellular source of matrix components in liver diseases. We found the peroxynitrite generator SIN-1 to promote apoptosis in human and rat HSC, based on oligonucleosomal DNA fragmentation, caspase-3 and -9 activation, Bcl-2 depletion and accumulation of Bax protein. We also showed that SIN-1-induced apoptosis of HSC was due to protein nitration. Among the tyrosine-nitrated proteins, tyrosine kinase Lyn was identified. SIN-1 triggered a signaling pathway through Src kinase Lyn activation that resulted in increased activity of the tyrosine kinase Syk. The involvement of these signaling molecules in the apoptotic process induced by SIN-1 as well as the mechanism by which they are activated was confirmed by using specific inhibitors. In summary, NO, via protein-nitration, could play an important role in controlling liver fibrosis resolution by regulation of HSC apoptosis.


Subject(s)
Apoptosis , Hepatic Stellate Cells/metabolism , Molsidomine/analogs & derivatives , Nitric Oxide/metabolism , Peroxynitrous Acid/metabolism , Animals , Caspase 3/metabolism , Caspase 9/metabolism , Cell Line , DNA Fragmentation , Humans , Inflammation/metabolism , Intracellular Signaling Peptides and Proteins/metabolism , Liver Cirrhosis/metabolism , Molsidomine/metabolism , Molsidomine/pharmacology , Protein-Tyrosine Kinases/metabolism , Rats , Signal Transduction , Syk Kinase , Tyrosine/metabolism , src-Family Kinases/metabolism
2.
Apoptosis ; 13(11): 1356-67, 2008 Nov.
Article in English | MEDLINE | ID: mdl-18819005

ABSTRACT

The sustained overproduction of nitric oxide (NO) observed in inflammatory conditions can contribute to cell demise by affecting apoptosis. Nitration of tyrosine residues occurs in a range of diseases involving macrophage activation. Since NO induces apoptosis in monocytes/macrophages, we tested the hypothesis that nitration of specific proteins could result in apoptotic cell death. The peroxynitrite generator SIN-1 promoted apoptosis in monocytes based on oligonucleosomal DNA fragmentation, caspase-3 and -9 activation, Bcl-2 depletion and accumulation of Bax and p53 proteins. We also found that the signaling pathway triggered by SIN-1 was initiated through tyrosine kinase and Rac activation and resulted in increased JNK and p38 activities. Among the tyrosine-nitrated proteins, Rac and Lyn were identified. Using specific inhibitors for different signaling and effector molecules involved in the apoptotic process we demonstrate that NO, via protein-nitration, could play an important role in controlling the inflammatory response by regulation of monocyte homeostasis.


Subject(s)
Apoptosis , Monocytes/metabolism , Nitric Oxide/metabolism , Caspase 3/metabolism , Caspase 9/metabolism , DNA Fragmentation , Humans , Inflammation , Leukocytes, Mononuclear/metabolism , MAP Kinase Kinase 4/metabolism , MAP Kinase Signaling System , Macrophages/metabolism , Models, Biological , Nitrogen/chemistry , Signal Transduction
3.
J Clin Endocrinol Metab ; 93(6): 2319-27, 2008 Jun.
Article in English | MEDLINE | ID: mdl-18349065

ABSTRACT

OBJECTIVES: We hypothesized that the CD40/CD40 ligand (CD40L) system is up-regulated in the metabolic syndrome (MS) and modulated by adiponectin (AN). The objectives were: 1) to compare plasma and monocyte CD40L in patients with MS and controls and its association with clinical and biochemical parameters, 2) to investigate platelets as a source of soluble CD40L (sCD40L), and 3) to analyze the effects of AN on CD40/CD40L. METHODS: Plasma sCD40L and AN were measured in 246 controls and 128 patients with MS by ELISA. Monocyte CD40/CD40L expression and platelet CD40L content and release were compared in patients with MS and controls. Monocytes and endothelial cells were cultured with AN and CD40/CD40L expression determined by real-time RT-PCR and Western blotting. RESULTS: Patients with MS had higher sCD40L and lower AN levels than controls (0.89 +/- 0.1 vs. 0.76 +/- 0.07 ng/ml and 10.10 +/- 0.65 vs. 12.99 +/- 0.80 microg /ml, P < 0.05). Monocyte CD40/CD40L expression was higher (P < 0.05) in patients than controls (CD40: 1.31 +/- 0.31 vs. 0.80 +/- 0.14 arbitrary units; CD40L: 1.24 +/- 0.85 vs. 0.43 +/- 0.14 pg/microg protein). No differences were observed on CD40L content between resting platelets from patients with MS and controls (7.7 +/- 3.5 vs. 7.2 +/- 2.2 pg/microg protein). Stimulated platelets from patients with the MS released more (P < 0.05) sCD40L than controls (582 +/- 141 vs. 334 +/- 60% change vs. nonstimulated platelets). AN reduced CD40L mRNA and protein expression in monocytes from MS patients and endothelial cells. CONCLUSIONS: The enhanced sCD40L and cellular CD40L expression in the MS suggests that CD40L is of pathophysiological relevance in MS. Also, a new antiinflammatory effect of AN is described through the modulation of the CD40/CD40L system.


Subject(s)
CD40 Ligand/genetics , Metabolic Syndrome/genetics , Adiponectin/blood , Adiponectin/pharmacology , Adult , Aged , Blood Platelets/drug effects , Blood Platelets/metabolism , CD40 Antigens/genetics , CD40 Antigens/metabolism , CD40 Ligand/blood , CD40 Ligand/metabolism , Cells, Cultured , Endothelial Cells/drug effects , Endothelial Cells/metabolism , Female , Humans , Inflammation Mediators/blood , Inflammation Mediators/metabolism , Male , Metabolic Syndrome/blood , Metabolic Syndrome/metabolism , Middle Aged , Monocytes/drug effects , Monocytes/metabolism , RNA, Messenger/metabolism , Up-Regulation/drug effects
4.
Am J Physiol Endocrinol Metab ; 294(1): E52-60, 2008 Jan.
Article in English | MEDLINE | ID: mdl-17940213

ABSTRACT

Adipose tissue is a target for cardiotrophin-1 (CT-1), a cytokine member of the IL-6 family of cytokines that is involved in cardiac growth and dysfunction. However, it is unknown whether adipocytes are a source of CT-1 and whether CT-1 is overexpressed in diseases characterized by increased fat depots [i.e., the metabolic syndrome (MS)]. Thus this work aimed 1) to test whether adipose tissue expresses CT-1 and whether CT-1 expression can be modulated and 2) to compare serum CT-1 levels in subjects with and without MS diagnosed by National Cholesterol Education Program Adult Treatment Panel III criteria. Gene and protein expression of CT-1 was determined by real-time RT-PCR, ELISA, and Western blotting. CT-1 expression progressively increased, along with differentiation time from preadipocyte to mature adipocyte in 3T3-L1 cells. CT-1 expression was enhanced by glucose in a dose-dependent manner in these cells. mRNA and protein CT-1 expression was also demonstrated in human adipose biopsies. Immunostaining showed positive staining in adipocytes. Finally, increased CT-1 serum levels were observed in patients with MS compared with control subjects (127 +/- 9 vs. 106 +/- 4 ng/ml, P < 0.05). Circulating levels of CT-1 were associated with glucose levels (r = 0.2, P < 0.05). Taken together, our data suggest that adipose tissue can be recognized as a source of CT-1, which could account for the high circulating levels of CT-1 in patients with MS.


Subject(s)
Adipocytes/physiology , Adipose Tissue/physiology , Cytokines/genetics , Metabolic Syndrome/metabolism , Metabolic Syndrome/physiopathology , 3T3-L1 Cells , Adipocytes/cytology , Adipose Tissue/cytology , Adult , Aged , Animals , Biopsy , Cytokines/metabolism , Female , Humans , Male , Metabolic Syndrome/pathology , Mice , Middle Aged , Obesity/metabolism , Obesity/physiopathology , RNA, Messenger/metabolism , Up-Regulation/physiology
5.
Clin Sci (Lond) ; 111(5): 341-7, 2006 Nov.
Article in English | MEDLINE | ID: mdl-16856875

ABSTRACT

The soluble form of CD40L (CD40 ligand), a pro-atherogenic mediator, has emerged as a diagnostic and prognostic marker for cardiovascular events. However, as platelets can shed CD40L upon activation, accurate measurement has proved challenging. The present study addresses the controversy regarding the appropriate specimen and preparation for laboratory evaluation of blood sCD40L (soluble CD40L). Serum and plasma (collected in EDTA, citrate or heparin) were collected from healthy volunteers (n=20), and sCD40L was analysed by ELISA immediately or after one to three freeze-thaw cycles and at different centrifugation speeds. Urine sCD40L levels were measured in subjects with low- and high-plasma sCD40L levels. Serum sCD40L levels (5.45+/-4.55 ng/ml; P<0.001) were higher than in citrate, EDTA or heparin plasma (1.03+/-1.07, 1.43+/-1.03 or 1.80+/-1.25 ng/ml respectively), with no significant differences between plasma preparations. Increasing g values (200-13000 g), which gradually deplete plasma of platelets, yielded lower sCD40L levels. Repeated freeze-thaw cycles significantly (P<0.05) increased sCD40L concentrations in platelet-rich, but not platelet-depleted, plasma (up to 2.4-fold). Bilirubin and haemoglobin interfered positively, and triacylglycerols (triglycerides) and cholesterol quenched CD40L signalling. No sCD40L was detected in urine samples. In conclusion, serum yields higher sCD40L concentrations than plasma; accurate measurements of sCD40L require exclusion of platelets and avoiding their post-hoc activation. Samples with high concentrations of bilirubin, haemoglobin and/or triacylglycerols should be excluded, as these substances interfere with the assay.


Subject(s)
Blood Specimen Collection/methods , CD40 Ligand/blood , Adult , Bilirubin/pharmacology , Biomarkers/blood , Blood Platelets/chemistry , Blood Preservation/methods , CD40 Ligand/drug effects , CD40 Ligand/urine , Citric Acid , Cryopreservation , Edetic Acid , Enzyme-Linked Immunosorbent Assay/methods , Hemoglobins/pharmacology , Heparin , Humans , Lipids/pharmacology , Middle Aged , Plasma/chemistry , Serum/chemistry , Solubility
SELECTION OF CITATIONS
SEARCH DETAIL
...